Shandong Pharmaceutical Glass Co Ltd (600529) - Total Assets
Based on the latest financial reports, Shandong Pharmaceutical Glass Co Ltd (600529) holds total assets worth CN¥10.14 Billion CNY (≈ $1.48 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shandong Pharmaceutical Glass Co Ltd - Total Assets Trend (1999–2025)
This chart illustrates how Shandong Pharmaceutical Glass Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Shandong Pharmaceutical Glass Co Ltd (600529) total market value for the company's overall valuation and market capitalisation.
Shandong Pharmaceutical Glass Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Shandong Pharmaceutical Glass Co Ltd's total assets of CN¥10.14 Billion consist of 59.9% current assets and 40.1% non-current assets. Review 600529 liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.7% |
| Accounts Receivable | CN¥1.49 Billion | 14.8% |
| Inventory | CN¥1.70 Billion | 16.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥241.97 Million | 2.4% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (1999–2025)
This chart illustrates how Shandong Pharmaceutical Glass Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 600529 stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Pharmaceutical Glass Co Ltd's current assets represent 59.9% of total assets in 2025, a decrease from 61.7% in 1999.
- Cash Position: Cash and equivalents constituted 10.7% of total assets in 2025, up from 8.0% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 1.0% in 1999.
- Asset Diversification: The largest asset category is inventory at 16.9% of total assets.
Shandong Pharmaceutical Glass Co Ltd Competitors by Total Assets
Key competitors of Shandong Pharmaceutical Glass Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Winpak Ltd.
TO:WPK
|
Canada | CA$1.59 Billion |
|
Jinfu Technology Co Ltd
SHE:003018
|
China | CN¥3.03 Billion |
|
Suzhou Hycan Holdings Co Ltd
SHE:002787
|
China | CN¥2.98 Billion |
|
Zhejiang Great Southeast Co Ltd
SHE:002263
|
China | CN¥2.97 Billion |
|
ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd
SHG:603976
|
China | CN¥1.95 Billion |
|
Zhejiang Jinsheng New Materials Co
SHE:300849
|
China | CN¥724.92 Million |
|
XiAn Global Printing Co Ltd
SHE:002799
|
China | CN¥1.90 Billion |
|
Metsa Board Oyj A
HE:METSA
|
Finland | €2.89 Billion |
Shandong Pharmaceutical Glass Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.79 | 3.34 | 2.12 |
| Quick Ratio | 2.75 | 2.55 | 1.58 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥4.49 Billion | CN¥4.24 Billion | CN¥1.65 Billion |
Shandong Pharmaceutical Glass Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shandong Pharmaceutical Glass Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.46 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | -0.9% |
| Total Assets | CN¥10.04 Billion |
| Market Capitalization | $1.82 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Pharmaceutical Glass Co Ltd's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shandong Pharmaceutical Glass Co Ltd's assets decreased by 0.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shandong Pharmaceutical Glass Co Ltd (1999–2025)
The table below shows the annual total assets of Shandong Pharmaceutical Glass Co Ltd from 1999 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥10.04 Billion ≈ $1.47 Billion |
-0.95% |
| 2024-12-31 | CN¥10.14 Billion ≈ $1.48 Billion |
+8.81% |
| 2023-12-31 | CN¥9.32 Billion ≈ $1.36 Billion |
+6.08% |
| 2022-12-31 | CN¥8.78 Billion ≈ $1.29 Billion |
+37.05% |
| 2021-12-31 | CN¥6.41 Billion ≈ $937.94 Million |
+14.02% |
| 2020-12-31 | CN¥5.62 Billion ≈ $822.59 Million |
+8.73% |
| 2019-12-31 | CN¥5.17 Billion ≈ $756.57 Million |
+11.82% |
| 2018-12-31 | CN¥4.62 Billion ≈ $676.59 Million |
+10.61% |
| 2017-12-31 | CN¥4.18 Billion ≈ $611.69 Million |
+7.07% |
| 2016-12-31 | CN¥3.90 Billion ≈ $571.31 Million |
+31.32% |
| 2015-12-31 | CN¥2.97 Billion ≈ $435.05 Million |
+5.50% |
| 2014-12-31 | CN¥2.82 Billion ≈ $412.39 Million |
+4.17% |
| 2013-12-31 | CN¥2.71 Billion ≈ $395.89 Million |
+3.57% |
| 2012-12-31 | CN¥2.61 Billion ≈ $382.24 Million |
+4.71% |
| 2011-12-31 | CN¥2.49 Billion ≈ $365.03 Million |
-1.15% |
| 2010-12-31 | CN¥2.52 Billion ≈ $369.30 Million |
+13.85% |
| 2009-12-31 | CN¥2.22 Billion ≈ $324.38 Million |
+11.56% |
| 2008-12-31 | CN¥1.99 Billion ≈ $290.77 Million |
+6.18% |
| 2007-12-31 | CN¥1.87 Billion ≈ $273.84 Million |
+14.77% |
| 2006-12-31 | CN¥1.63 Billion ≈ $238.61 Million |
+14.36% |
| 2005-12-31 | CN¥1.43 Billion ≈ $208.65 Million |
+15.73% |
| 2004-12-31 | CN¥1.23 Billion ≈ $180.29 Million |
+18.92% |
| 2003-12-31 | CN¥1.04 Billion ≈ $151.60 Million |
+9.80% |
| 2002-12-31 | CN¥943.59 Million ≈ $138.08 Million |
+101.95% |
| 2001-12-31 | CN¥467.24 Million ≈ $68.37 Million |
+18.40% |
| 2000-12-31 | CN¥394.61 Million ≈ $57.74 Million |
+11.65% |
| 1999-12-31 | CN¥353.45 Million ≈ $51.72 Million |
-- |
About Shandong Pharmaceutical Glass Co Ltd
Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection v… Read more